FDA Fast Track designation given to Enterome’s follicular lymphoma treatment
Follicular lymphoma, a type of non-Hodgkin’s lymphoma, has few initial symptoms
Read More
Section: Regulatory
GSK’s Blenrep approved by FDA for multiple myeloma
Approval supported by positive results from phase 3 trial
Read More
ViiV Healthcare receives NICE recommendation for HIV prevention therapy
The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales
Read More
Pelage Pharmaceuticals’ alopecia treatment moves forward to phase 3 trial
The news follows positive phase 2a results for the androgenetic alopecia treatment
Read More
MHRA marks 100 years of patient safety through biological standards
The UK regulator highlights its century-long role in establishing safety and consistency benchmarks
Read More